In patients with advanced, unresectable NETs, there are several treatment options; which of these may be considered depends on the site of origin of the tumor.
Arvind Dasari, MD
Advertisement
Articles by Arvind Dasari, MD
Advertisement
Latest Updated Articles
- Initial Treatment of Well-Differentiated Neuroendocrine Tumors
November 15th 2014
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Accepts NDA for Daraxonrasib in Pretreated Metastatic Pancreatic Cancer
2
Homologous Recombination and Mismatch Repair Assessment in Men With Advanced Prostate Cancer: A Cross-Sectional Study From a Center in Mexico City
3
Teclistamab Combos Improve PFS, OS in Relapsed/Refractory Multiple Myeloma
4
Bridging CAR T-Cell and Bispecific Therapy Access in Community Oncology
5